
|Videos|May 31, 2019
Dr Wayne Burton Discusses Key Takeaways From Migraine Peer Exchange
Wayne Burton, MD, former global corporate medical director for American Express, discusses what he views as the key takeaways from a migraine peer exchange he recently participated in.
Advertisement
Transcript:
You recently participated in a peer exchange discussion on migraine. What were some key takeaways from that conversation?
There were a number of highlights and takeaways from the peer exchange. We realized that migraine now affects more than 40 million Americans; many of them, [a] large number— perhaps over 40%– are not diagnosed or are misdiagnosed and there’s lots of opportunities now with new treatments especially for episodic and chronic patients with migraine.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
2
MFN Drug Agreements Could Raise Prices Worldwide
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
5




